14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.05 $2.79 Tuesday, 23rd Apr 2024 FGEN stock ended at $1.07. This is 6.14% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 20.00% from a day low at $1.05 to a day high of $1.26.
90 days $0.85 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Apr 29, 2021 $22.33 $23.04 $21.83 $22.51 1 163 940
Apr 28, 2021 $21.57 $22.37 $21.23 $22.24 1 072 402
Apr 27, 2021 $21.78 $21.92 $21.35 $21.53 783 246
Apr 26, 2021 $21.81 $21.81 $21.21 $21.64 952 606
Apr 23, 2021 $21.13 $21.41 $20.68 $21.14 929 554
Apr 22, 2021 $21.04 $21.65 $20.51 $21.12 1 387 760
Apr 21, 2021 $20.13 $21.06 $19.70 $21.06 1 396 758
Apr 20, 2021 $18.95 $20.38 $18.77 $20.35 2 441 151
Apr 19, 2021 $19.62 $19.77 $18.91 $19.00 1 656 915
Apr 16, 2021 $19.34 $20.00 $18.91 $19.91 3 882 822
Apr 15, 2021 $19.36 $19.99 $19.10 $19.30 1 785 534
Apr 14, 2021 $19.59 $20.07 $19.12 $19.26 1 742 461
Apr 13, 2021 $19.21 $19.87 $18.80 $19.73 2 221 839
Apr 12, 2021 $18.80 $20.25 $18.41 $19.89 3 777 696
Apr 09, 2021 $18.74 $18.98 $18.12 $18.57 4 074 879
Apr 08, 2021 $19.36 $19.86 $18.64 $18.81 7 180 881
Apr 07, 2021 $23.87 $23.98 $19.71 $19.74 20 005 055
Apr 06, 2021 $35.32 $35.80 $34.50 $34.64 887 243
Apr 05, 2021 $35.89 $36.06 $34.64 $35.63 504 154
Apr 01, 2021 $35.29 $36.13 $34.25 $35.68 900 766
Mar 31, 2021 $32.41 $35.70 $32.17 $34.71 1 369 869
Mar 30, 2021 $31.00 $32.15 $30.88 $31.11 1 082 504
Mar 29, 2021 $31.39 $32.15 $30.96 $31.00 591 714
Mar 26, 2021 $31.30 $31.96 $30.81 $31.91 451 710
Mar 25, 2021 $31.15 $31.80 $30.77 $31.32 1 156 245
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT